Call for Abstracts

Abstract Submission is NOW OPEN


The Core Program and Regional Organizing Committee for the IASLC 17th World Conference on Lung Cancer are inviting the submission of scientific abstracts. Authors are asked to submit abstracts under one of the following categories:

  • Epidemiology/Tobacco Control & Cessation/Prevention
  • Biology/Pathology
  • Radiology/Staging/Screening
  • Pulmonology
  • Early Stage NSCLC
  • Locally Advanced NSCLC
  • Advanced NSCLC
  • SCLC/Neuroendocrine Tumors
  • Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
  • Surgery
  • Radiotherapy
  • Chemotherapy/Targeted Therapy/Immunotherapy
  • Palliative Care/Ethics
  • Trial Design/Statistics
  • Regional Aspects/Health Policy/Public Health
  • Scientific Co-operation (Clinical Trials in Progress are to be submitted under this category)
  • Nurses
  • Patient Support & Advocacy Groups

Clinical Trials In Progress

The Conference will also accept submissions of abstracts on Clinical Trials in Progress. They should be submitted in the submission category ‘Scientific Co-operation/Research Group’.


Abstract Deadlines

Abstract Submission Open February 22, 2016
Abstract Submission Deadline July 15, 2016
Author Notification of Acceptance September 14, 2016
Late-Breaking Abstract Submission Deadline October 15, 2016
Presenting Author Registration Deadline October 21, 2016

Submission Guidelines

  • Research work should be original and innovative. Work can be presented prior to the IASLC 17th WCLC, but MUST include new information/data
  • Abstracts must be submitted electronically through the Conference website
  • Abstracts will be accepted in English only
  • The abstract title must not exceed 125 characters in length
  • Abstracts must not exceed 400 words in length (not including title and authors)
  • Tables may be included and each will count as 100 words
  • A maximum of 2 images may be included; each will count as 100 words
  • Tables, images and graphs must be uploaded in JPG or TIFF format at 300 dpi and 100% size. Any higher resolution is acceptable.
  • Abstracts must be structured with the following:
    • Background
    • Methods
    • Results
    • Conclusion
  • The presenting author of an accepted abstract must be registered by October 21, 2016
  • There is no fee for submitting an abstract
  • There is no limit to the number of co-authors per abstract
  • There is no limit to the number of abstracts you may submit (however an individual may not be offered more than 2 oral presentations)
  • An international panel of reviewers will review all abstracts anonymously
  • All Abstracts accepted by the Scientific Committee will be published in the Journal of Thoracic Oncology (JTO) and the Conference website prior to the meeting and it is mandatory to agree to this at the time of submission
  • Financial Disclosure information needs to be completed for EACH co-author at the time of submission through the online abstract submission form; however, information can be provided by the submitting author

Late-Breaking Abstract Submissions

In order for an abstract to be considered for Late Breaking Abstract status, the submitting author must submit a place holder abstract before the July 15, 2016, deadline. The results and conclusion can be omitted but the type of data that will be presented in the Late-Breaking Abstract must be described as well as why Late-Breaking status is required. 

If you wish to apply for late breaking privileges, you must submit an abstract by the regular submission deadline July 15, 2016. To apply for late breaking privileges you must sent an email to wclc2016-abstracts at, indicating your abstract ID number and explaining why data is not yet available and when you expect it to become available. The Core Program Committee will then review your abstract and application. If your application is approved you will be notified and instructed on how to submit your new data by the end of August 2016.



For any inquiries, please contact wclc2016-abstracts at